N-sulfonylated tetrahydroquinolines and related bicyclic compounds for inhibition of RORγ activity and the treatment of disease
US-9512111-B2 · Dec 6, 2016 · US
This page is not indexed by search engines while we improve data quality.
Glick Gary D patents
Glick Gary D holds 5 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 5 |
| Recent patents | 0 |
| First publication | Jan 29, 2015 |
| Latest publication | Dec 6, 2016 |
Filing trend
Year-over-year patent counts for this assignee.
Recent patents
Latest publications where this party is an assignee.
Pyrazolyl guanidine F1F0-atpase inhibitors and therapeutic uses thereof
US-9139532-B2 · Sep 22, 2015 · US
1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
US-9126978-B2 · Sep 8, 2015 · US
Pyridonyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof
US-9000014-B2 · Apr 7, 2015 · US
Methods and compositions for detecting immune system activation
US-2015031068-A1 · Jan 29, 2015 · US
Notable patents
Representative or frequently cited publications from precomputed assignee stats.
N-sulfonylated tetrahydroquinolines and related bicyclic compounds for inhibition of RORγ activity and the treatment of disease
US-9512111-B2 · Dec 6, 2016 · US
Pyrazolyl guanidine F1F0-atpase inhibitors and therapeutic uses thereof
US-9139532-B2 · Sep 22, 2015 · US
1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
US-9126978-B2 · Sep 8, 2015 · US
Pyridonyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof
US-9000014-B2 · Apr 7, 2015 · US
Methods and compositions for detecting immune system activation
US-2015031068-A1 · Jan 29, 2015 · US
Top CPC classifications
Most common classification codes in this portfolio.
Technology areas
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 4 |
| Chemistry & Metallurgy | 4 |
| Physics | 1 |